echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > 5.9 billion settlement! More than 1200 medical institutions have settled in the new drug purchase platform of Zhejiang Province

    5.9 billion settlement! More than 1200 medical institutions have settled in the new drug purchase platform of Zhejiang Province

    • Last Update: 2017-03-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: Zhejiang medical equipment procurement center March 6, 2017 health Zhejiang received information from Zhejiang medical equipment procurement center As of February 28, 2017, the online cumulative settlement amount of Zhejiang new drug procurement platform reached more than 5.9 billion yuan Among them, 4.245 billion yuan is for provincial medical institutions, 928 million yuan for Hangzhou, 550 million yuan for Shaoxing, and nearly 180 million yuan for other cities It is reported that since the launch of the new drug purchase platform in Zhejiang Province on June 1, 2016, it has taken four months to realize the first online unified settlement scale of 1 billion yuan, while at present, it only takes one week to realize the unified settlement of 1 billion yuan According to Zhejiang medical equipment procurement center, the unified settlement of the new platform has three characteristics: 1 The number of online payment medical institutions has increased significantly, and the number of online payment medical institutions has expanded from 15 pilot units to 196 medical and health institutions More than 1200 medical institutions have been purchased on the new platform, and more than 800 will switch to the new platform in March 2 The growth rate of online payment is significant In the last four months, the cumulative settlement amount has exceeded 4 billion yuan 3 The payment behavior is further standardized, the payment time is shortened, and the efficiency is significantly improved.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.